Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
9.02M
-
Shares change
-
+3.64M
-
Total reported value, excl. options
-
$9.56M
-
Value change
-
+$3.85M
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$1.06
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2022
22 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q1 2022.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.02M shares
of 386M outstanding shares and own 2.34% of the company stock.
Largest 10 shareholders include HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (2.41M shares), STONEHILL CAPITAL MANAGEMENT LLC (2.27M shares), RENAISSANCE TECHNOLOGIES LLC (1.47M shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (1.15M shares), ACADIAN ASSET MANAGEMENT LLC (815K shares), Whitefort Capital Management, LP (410K shares), MORGAN STANLEY (108K shares), LPL Financial LLC (102K shares), ENVESTNET ASSET MANAGEMENT INC (98.1K shares), and MILLENNIUM MANAGEMENT LLC (42.4K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.